D-0173-2023 Class II Terminated
FDA drug recall D-0173-2023 was initiated by Preferred Pharmaceuticals, Inc. on January 16, 2023 and is designated Class II. Reason for recall: Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet. The recall status is terminated (terminated April 14, 2023). Affected quantity: 9 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- February 1, 2023
- Initiation Date
- January 16, 2023
- Termination Date
- April 14, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9 bottles
Product Description
Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.
Reason for Recall
Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Distribution Pattern
IN
Code Information
Lot: K3022Q, Expiration date: 3/31/2025